OptiBiotix Health (LON:OPTI) Announces Earnings Results

OptiBiotix Health (LON:OPTI) released its quarterly earnings results on Thursday. The company reported GBX (1.52) earnings per share for the quarter, Digital Look Earnings reports. OptiBiotix Health had a negative net margin of 332.69% and a negative return on equity of 77.85%.

OptiBiotix Health Price Performance

LON:OPTI remained flat at GBX 5.95 during midday trading on Friday. 580,627 shares of the company traded hands, compared to its average volume of 359,691. The stock has a 50-day simple moving average of GBX 5.78 and a two-hundred day simple moving average of GBX 5.74. The firm has a market cap of £6.15 million, a P/E ratio of -1.55 and a beta of 1.82. OptiBiotix Health has a one year low of GBX 4.50 and a one year high of GBX 12.25.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.